Medicare Physician Payment Reform Bill Offers Opportunity For Biopharma Input
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation to replace Medicare’s sustainable growth rate formula with value-based physician pay, being jointly developed by the Senate Finance Committee and House Ways and Means Committee, could be a vehicle for the biopharma industry to seek inclusion of drug-friendly policies. The committees released their discussion draft for SGR reform Oct. 31.